Predicting pathologic ≥N2 disease in women with breast cancer
Abstract The distinction between pN1 and ≥pN2 breast cancer impacts treatment decisions. Using data from a single institution on women with cN0 invasive breast cancer who were treated with upfront surgery, had 1-3 positive SLNs, and underwent completion ALND, we used gradient boosted trees (XGBoost)...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | npj Breast Cancer |
| Online Access: | https://doi.org/10.1038/s41523-025-00757-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850269111990353920 |
|---|---|
| author | Kerollos Nashat Wanis Wenli Dong Yu Shen Funda Meric-Bernstam Taiwo Adesoye Henry M. Kuerer Abigail S. Caudle Nina Tamirisa Sarah M. DeSnyder Susie X. Sun Isabelle Bedrosian Puneet Singh Solange E. Cox Kelly K. Hunt Rosa F. Hwang |
| author_facet | Kerollos Nashat Wanis Wenli Dong Yu Shen Funda Meric-Bernstam Taiwo Adesoye Henry M. Kuerer Abigail S. Caudle Nina Tamirisa Sarah M. DeSnyder Susie X. Sun Isabelle Bedrosian Puneet Singh Solange E. Cox Kelly K. Hunt Rosa F. Hwang |
| author_sort | Kerollos Nashat Wanis |
| collection | DOAJ |
| description | Abstract The distinction between pN1 and ≥pN2 breast cancer impacts treatment decisions. Using data from a single institution on women with cN0 invasive breast cancer who were treated with upfront surgery, had 1-3 positive SLNs, and underwent completion ALND, we used gradient boosted trees (XGBoost) to develop a model for predicting ≥pN2 disease using clinicopathologic variables. Model performance was tested in a held-out subsample (20%) and validated using data from the National Cancer Database (NCDB). Of 3574 patients with cN0 breast cancer, 587 underwent upfront surgery and had 1-3 positive SLNs. Of these, 415 (70.7%) underwent completion ALND, with 64 (15.4%) having ≥pN2 disease. The trained algorithm had an AUC of 0.87 (95% CI: 0.74, 0.97) in the held-out test data, and 0.78 (95% CI: 0.76, 0.79) in recent NCDB data where completion ALND was much less commonly performed. The number of positive SLNs and the total number of SLNs removed had the greatest influence on model predictions in the held-out test data. The developed model effectively estimates the probability of ≥pN2 disease in cN0 patients with positive SLNs, providing guidance for the management of patients with breast cancer. |
| format | Article |
| id | doaj-art-c12f361481f14a4e9496c22cec2365bc |
| institution | OA Journals |
| issn | 2374-4677 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | npj Breast Cancer |
| spelling | doaj-art-c12f361481f14a4e9496c22cec2365bc2025-08-20T01:53:15ZengNature Portfolionpj Breast Cancer2374-46772025-05-011111810.1038/s41523-025-00757-4Predicting pathologic ≥N2 disease in women with breast cancerKerollos Nashat Wanis0Wenli Dong1Yu Shen2Funda Meric-Bernstam3Taiwo Adesoye4Henry M. Kuerer5Abigail S. Caudle6Nina Tamirisa7Sarah M. DeSnyder8Susie X. Sun9Isabelle Bedrosian10Puneet Singh11Solange E. Cox12Kelly K. Hunt13Rosa F. Hwang14Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer CenterDepartment of Biostatistics, The University of Texas MD Anderson Cancer CenterDepartment of Biostatistics, The University of Texas MD Anderson Cancer CenterDepartment of Breast Surgical Oncology, The University of Texas MD Anderson Cancer CenterDepartment of Breast Surgical Oncology, The University of Texas MD Anderson Cancer CenterDepartment of Breast Surgical Oncology, The University of Texas MD Anderson Cancer CenterDepartment of Breast Surgical Oncology, The University of Texas MD Anderson Cancer CenterDepartment of Breast Surgical Oncology, The University of Texas MD Anderson Cancer CenterDepartment of Breast Surgical Oncology, The University of Texas MD Anderson Cancer CenterDepartment of Breast Surgical Oncology, The University of Texas MD Anderson Cancer CenterDepartment of Breast Surgical Oncology, The University of Texas MD Anderson Cancer CenterDepartment of Breast Surgical Oncology, The University of Texas MD Anderson Cancer CenterDepartment of Breast Surgical Oncology, The University of Texas MD Anderson Cancer CenterDepartment of Breast Surgical Oncology, The University of Texas MD Anderson Cancer CenterDepartment of Breast Surgical Oncology, The University of Texas MD Anderson Cancer CenterAbstract The distinction between pN1 and ≥pN2 breast cancer impacts treatment decisions. Using data from a single institution on women with cN0 invasive breast cancer who were treated with upfront surgery, had 1-3 positive SLNs, and underwent completion ALND, we used gradient boosted trees (XGBoost) to develop a model for predicting ≥pN2 disease using clinicopathologic variables. Model performance was tested in a held-out subsample (20%) and validated using data from the National Cancer Database (NCDB). Of 3574 patients with cN0 breast cancer, 587 underwent upfront surgery and had 1-3 positive SLNs. Of these, 415 (70.7%) underwent completion ALND, with 64 (15.4%) having ≥pN2 disease. The trained algorithm had an AUC of 0.87 (95% CI: 0.74, 0.97) in the held-out test data, and 0.78 (95% CI: 0.76, 0.79) in recent NCDB data where completion ALND was much less commonly performed. The number of positive SLNs and the total number of SLNs removed had the greatest influence on model predictions in the held-out test data. The developed model effectively estimates the probability of ≥pN2 disease in cN0 patients with positive SLNs, providing guidance for the management of patients with breast cancer.https://doi.org/10.1038/s41523-025-00757-4 |
| spellingShingle | Kerollos Nashat Wanis Wenli Dong Yu Shen Funda Meric-Bernstam Taiwo Adesoye Henry M. Kuerer Abigail S. Caudle Nina Tamirisa Sarah M. DeSnyder Susie X. Sun Isabelle Bedrosian Puneet Singh Solange E. Cox Kelly K. Hunt Rosa F. Hwang Predicting pathologic ≥N2 disease in women with breast cancer npj Breast Cancer |
| title | Predicting pathologic ≥N2 disease in women with breast cancer |
| title_full | Predicting pathologic ≥N2 disease in women with breast cancer |
| title_fullStr | Predicting pathologic ≥N2 disease in women with breast cancer |
| title_full_unstemmed | Predicting pathologic ≥N2 disease in women with breast cancer |
| title_short | Predicting pathologic ≥N2 disease in women with breast cancer |
| title_sort | predicting pathologic ≥n2 disease in women with breast cancer |
| url | https://doi.org/10.1038/s41523-025-00757-4 |
| work_keys_str_mv | AT kerollosnashatwanis predictingpathologicn2diseaseinwomenwithbreastcancer AT wenlidong predictingpathologicn2diseaseinwomenwithbreastcancer AT yushen predictingpathologicn2diseaseinwomenwithbreastcancer AT fundamericbernstam predictingpathologicn2diseaseinwomenwithbreastcancer AT taiwoadesoye predictingpathologicn2diseaseinwomenwithbreastcancer AT henrymkuerer predictingpathologicn2diseaseinwomenwithbreastcancer AT abigailscaudle predictingpathologicn2diseaseinwomenwithbreastcancer AT ninatamirisa predictingpathologicn2diseaseinwomenwithbreastcancer AT sarahmdesnyder predictingpathologicn2diseaseinwomenwithbreastcancer AT susiexsun predictingpathologicn2diseaseinwomenwithbreastcancer AT isabellebedrosian predictingpathologicn2diseaseinwomenwithbreastcancer AT puneetsingh predictingpathologicn2diseaseinwomenwithbreastcancer AT solangeecox predictingpathologicn2diseaseinwomenwithbreastcancer AT kellykhunt predictingpathologicn2diseaseinwomenwithbreastcancer AT rosafhwang predictingpathologicn2diseaseinwomenwithbreastcancer |